Silverlink Communications, Inc. – Trademark Portfolio
Entity Type: 03
Silverlink Communications, Inc. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 12 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ACUMEN and ENGAGEME. The owner is based in Burlington, MA.
67 South Bedford Street
Suite 300E
Burlington, MA 01803
Showing of trademarks Trademarks
Trademark Classifications
Silverlink Communications, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Silverlink Communications, Inc. have?
Silverlink Communications, Inc. has 13 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 abandoned, 6 cancelled.
What trademark classes does Silverlink Communications, Inc. file in?
Silverlink Communications, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Silverlink Communications, Inc.'s most well-known trademarks?
Silverlink Communications, Inc.'s registered trademark portfolio includes well-known marks such as ACUMEN and ENGAGEME. These are among 2 currently registered trademarks in the portfolio.
What is Silverlink Communications, Inc.'s trademark registration success rate?
Silverlink Communications, Inc. has a 15% trademark registration rate, with 2 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.